Rhode Island Senate Bill S2049

Rhode Island 2026 Regular Session

• Introduced: 1/9/26
• Refer: 1/9/26

Caption

Establishes a program within the adult correctional institution to permit medication assisted treatment approved by the FDA to be provided for the treatment of opioid use disorder to any incarcerated individual.

Impact

This legislative measure is significant as it represents a proactive approach to address the opioid crisis within the correctional system, recognizing opioid use disorder as a medical condition requiring treatment rather than purely punitive measures. It is designed to enhance the well-being of inmates while potentially reducing recidivism rates by addressing underlying addiction issues. The program aims to facilitate support for individuals as they transition back into society, thus impacting post-release recovery and managing public health concerns associated with opioid dependency.

Summary

Bill S2049 aims to establish a program within adult correctional institutions in Rhode Island to provide medication-assisted treatment for incarcerated individuals suffering from opioid use disorder. The program mandates that all incoming inmates be screened for opioid use disorder within 24 hours of admission, and those identified as needing treatment can voluntarily participate in a tailored program that incorporates FDA-approved medications for addiction treatment. The bill emphasizes the importance of individualized treatment plans developed in collaboration with qualified healthcare professionals.

Contention

Notably, the bill includes protections for inmates regarding their participation in the program, ensuring that disciplinary infractions do not preclude access to treatment. While the intent behind S2049 is generally seen as positive, potential concerns have been raised about the execution of the program and its sustainability. Critics might question the allocation of resources for such programs, the adequacy of treatment provided, and whether it effectively aligns with broader efforts to combat drug-related issues outside correctional facilities.